Skip to main content
SpringerLink
Log in

Adjuvante Pazopanib-Therapie nach (Teil-)Nephrektomie

AUO-Studie zum Nierenzellkarzinom

  • Fortbildung
  • Published:
Uro-News Aims and scope

Zusammenfassung

Die internationale multizentrische Studie PROTECT zum Nierenzellkarzinom wurde im Januar gestartet. In Deutschland sollen circa 175 Patienten rekrutiert werden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. MeckEvidence, Seestr. 11, 17252, Schwarz, Deutschland

    Heidrun Rexer

Authors
  1. Heidrun Rexer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heidrun Rexer.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rexer, H. Adjuvante Pazopanib-Therapie nach (Teil-)Nephrektomie. URO-News 15, 26–27 (2011). https://doi.org/10.1007/BF03369919

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03369919

Search

Navigation